Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Andrew Lees And NotÉtats-Unis

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
002108 Donald Grosset [Royaume-Uni] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Gianni Pezzoli [Italie] ; Andrew Lees [Royaume-Uni] ; Karen Shaw [Royaume-Uni] ; Esther Cubo [Espagne] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Laurence Negre-Pages [France] ; Ana Senard [France] ; Johannes Schwarz [Allemagne] ; Karl Strecker [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] ; Matthias Löhle [Allemagne] ; Fabrizio Stocchi [Italie] ; Katherine Grosset [Royaume-Uni]Adherence to antiparkinson medication in a multicenter European study
002278 Olivier Rascol [France] ; Werner Poewe [Autriche] ; Andrew Lees ; Marina Aristin ; Laurence Salin ; Nolwenn Juhel ; Lisa Waldhauser ; Thomas SchindlerTesofensine (NS 2330), a monoamine reuptake inhibitor, in patients with advanced Parkinson disease and motor fluctuations: the ADVANS Study.
002488 Olivier Rascol [France] ; Werner Poewe [Autriche] ; Andrew Lees [Royaume-Uni] ; Marina Aristin [France] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Lisa Waldhauser [Allemagne] ; Thomas Schindler [Allemagne]Tesofensine (NS 2330), a Monoamine Reuptake Inhibitor, in Patients With Advanced Parkinson Disease and Motor Fluctuations : The ADVANS Study
002997 Olivier Rascol [France] ; Bruno Dubois [France] ; Alexandre Castro Caldas [Portugal] ; Stephen Senn [Royaume-Uni] ; Susanna Del Signore [France] ; Andrew Lees [Royaume-Uni]Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study
002C75 Philippe Remy [France] ; Miroslava Doder [France] ; Andrew Lees [Royaume-Uni, France] ; Nora Turjanski [France] ; David Brooks [France]Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system
003379 Annie Lannuzel [France] ; Cécile Hermann [France] ; Chérine Yousry [France] ; Andrew Lees [Royaume-Uni] ; Dominique Caparros-Lefebvre [France]Encephalomyelitis with rigidity complicating human immunodeficiency virus infection
003515 Dominique Caparros-Lefebvre [France] ; Nicolas Sergeant [France] ; Andrew Lees [Royaume-Uni] ; Agnes Camuzat [France] ; Susan Daniel [Royaume-Uni] ; Annie Lannuzel [France] ; Alexis Brice [France] ; Eduardo Tolosa [Espagne] ; Andre Delacourte [France] ; Charles Duyckaerts [France]Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy
003D09 Dominique Caparros-Lefebvre [France] ; Andrew Lees [France]Atypical parkinsonism in the French West Indies
004084 J. M. Rascol [France] ; Kasia Sieradzan [Royaume-Uni] ; Hélène Peyro-Saint-Paul [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Jean Michel Senard [France] ; Philippe Ladure [France] ; Jean Louis Montastruc [France] ; Andrew Lees [Royaume-Uni]Efaroxan, an alpha‐2 antagonist, in the treatment of progressive supranuclear palsy
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024